Metraipolis › archive › dc_ae328cc1ce62
Sorafenib-to-regorafenib sequence-induced atherosclerotic cardiovascular disease: a novel case report — Europe PMC PMID:40936714
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40936714
- DOI
- 10.3389/fonc.2025.1615472
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T08:13:54.444Z
- SHA-256 of the archived text
c6649bb242eeff2e9caedf0aa4be317ece8e65fdd5690dcd55795ebc5213dbba- Stable URL of this page
https://metraipolis.com/documento/dc_ae328cc1ce62
How to cite
Sorafenib-to-regorafenib sequence-induced atherosclerotic cardiovascular disease: a novel case report — Europe PMC PMID:40936714 — Europe PMC (en), https://europepmc.org/article/MED/40936714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae328cc1ce62 (Metraipolis archive dc_ae328cc1ce62, sha256 c6649bb242eeff2e9caedf0aa4be317ece8e65fdd5690dcd55795ebc5213dbba)
BibTeX
@misc{dcae328cc1ce62,
title = {Sorafenib-to-regorafenib sequence-induced atherosclerotic cardiovascular disease: a novel case report — Europe PMC PMID:40936714},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40936714},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae328cc1ce62; sha256 c6649bb242eeff2e9caedf0aa4be317ece8e65fdd5690dcd55795ebc5213dbba},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40936714. Agents can read the archived copy with the MCP tool read_document.